The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of 68Ga-PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
 
Amelia Altavilla
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Janssen
 
Paola Caroli
No Relationships to Disclose
 
Emilio Francesco Giunta
No Relationships to Disclose
 
Emanuela Scarpi
No Relationships to Disclose
 
Virginia Rossetti
No Relationships to Disclose
 
Chiara Casadei
Travel, Accommodations, Expenses - Pfizer
 
Cristian Lolli
Consulting or Advisory Role - Ipsen; Janssen; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA
 
Giuseppe Schepisi
Consulting or Advisory Role - Janssen; Pfizer
 
Sara Bleve
No Relationships to Disclose
 
Maria Concetta Cursano
No Relationships to Disclose
 
Lorenzo Gasperoni
No Relationships to Disclose
 
Federica Matteucci
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer